CIK: 0001534261
Total reported value
$1.3B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Loxo Oncology INC | Stock-Other | 7.85% | — | -0.60% | |
| 2 | EPZMEUR | Epizyme INC | Stock-Other | 7.58% | — | +63.91% | |
| 3 | ✓ | Foundation Medicine INC | Stock-Other | 6.99% | — | +157.69% | |
| 4 | SG7 | Sage Therapeutics INC | Stock-Other | 6.95% | — | +32.16% | |
| 5 | AGIO | Agios Pharmaceuticals INC | Stock-Other | 6.90% | — | +45.81% | |
| 6 | 2655787D | Blueprint Medicines CORP | Stock-Other | 6.66% | — | -22.11% | |
| 7 | ALNY | Alnylam Pharmaceuticals INC | Stock-Healthcare | 6.48% | +0.03% | +50.00% | |
| 8 | ✓ | Stock-Other | 5.85% | — | — | ||
| 9 | MYOKEUR | Myokardia INC | Stock-Other | 5.84% | — | +17.70% | |
| 10 | ONCEEUR | Spark Therapeutics INC | Stock-Other | 5.76% | — | +17.24% | |
| 11 | CTMX | Cytomx Therapeutics INC | Stock-Other | 4.75% | — | — | |
| 12 | KRG | Kite Realty Group Trust | Stock-Real Estate | 3.95% | — | +150.00% | |
| 13 | VYGR | Voyager Therapeutics INC | Stock-Other | 3.40% | — | +43.27% | |
| 14 | EDIT | Editas Medicine INC | Stock-Other | 3.39% | — | — | |
| 15 | DXCM | Dexcom INC | Stock-Healthcare | 3.12% | -0.72% | EXIT | |
| 16 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 2.96% | — | — | |
| 17 | ✓ | Avexis INC | Stock-Other | 1.97% | — | — | |
| 18 | GBTUSD | Global Blood Therapeutics In | Stock-Other | 1.91% | — | +61.54% | |
| 19 | GHDX | Genomic Health INC | Stock-Other | 1.56% | — | -66.67% | |
| 20 | BMY | Bristol-myers Squibb Co | Stock-Healthcare | 1.54% | — | -34.71% | |
| 21 | BIIB | Biogen INC | Stock-Healthcare | 1.49% | — | -44.44% | |
| 22 | ONC | Beone Medicines Ltd-adr | Stock-Other | 1.09% | — | — | |
| 23 | ✓ | Ignyta INC | Stock-Other | 0.86% | — | — | |
| 24 | EXK | Exact Sciences CORP | Stock-Materials | 0.46% | — | — | |
| 25 | MDSOEUR | Medidata Solutions INC | Stock-Other | 0.44% | — | — | |
| 26 | OXLC | Oxford Lane Capital Corp. | Stock-Other | 0.23% | — | -73.33% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Foundation Medicine INC | +4.6% | +157.69% | Add |
| 2 | EPZMEUR | Epizyme INC | +2.9% | +63.91% | Add |
| 3 | KRG | Kite Realty Group Trust | +2.3% | +150.00% | Add |
| 4 | DXCM | Dexcom INC | +1.9% | +135.29% | Add |
| 5 | ✓ | Loxo Oncology INC | +1.5% | -0.60% | Trim |
| 6 | ALNY | Alnylam Pharmaceuticals INC | +1.5% | +50.00% | Add |
| 7 | AGIO | Agios Pharmaceuticals INC | +1.1% | +45.81% | Add |
| 8 | MYOKEUR | Myokardia INC | +0.6% | +17.70% | Add |
| 9 | GBTUSD | Global Blood Therapeutics In | +0.1% | +61.54% | Add |
| 10 | MDSOEUR | Medidata Solutions INC | — | — | Unchanged |
| 11 | ONCEEUR | Spark Therapeutics INC | 0% | +17.24% | Add |
| 12 | SG7 | Sage Therapeutics INC | -0.4% | +32.16% | Add |
| 13 | BMY | Bristol-myers Squibb Co | -0.4% | -34.71% | Trim |
| 14 | OXLC | Oxford Lane Capital Corp. | -0.5% | -73.33% | Trim |
| 15 | BIIB | Biogen INC | -1% | -44.44% | Trim |
| 16 | ✓ | -1% | — | Unchanged | |
| 17 | CTMX | Cytomx Therapeutics INC | -1.2% | — | Unchanged |
| 18 | VYGR | Voyager Therapeutics INC | -1.2% | +43.27% | Add |
| 19 | 2655787D | Blueprint Medicines CORP | -2.9% | -22.11% | Trim |
| 20 | GHDX | Genomic Health INC | -3.6% | -66.67% | Trim |
| 21 | ILMN | Illumina INC | — | EXIT | Sold out |
| 22 | EDIT | Editas Medicine INC | — | NEW | New buy |
| 23 | XBI | Ss Spdr S&p Biotech ETF | — | NEW | New buy |
| 24 | GNMK | Genmark Diagnostics INC | — | EXIT | Sold out |
| 25 | NVTA1EUR | Invitae CORP | — | EXIT | Sold out |
| 26 | ✓ | Avexis INC | — | NEW | New buy |
| 27 | OSUR | Orasure Technologies INC | — | EXIT | Sold out |
| 28 | ONC | Beone Medicines Ltd-adr | — | NEW | New buy |
| 29 | ✓ | Juno Therapeutics | — | EXIT | Sold out |
| 30 | ✓ | Ignyta INC | — | NEW | New buy |
| 31 | ATRAGBX | Atara Biotherapeutics INC | — | EXIT | Sold out |
| 32 | EXK | Exact Sciences CORP | — | NEW | New buy |
| 33 | ✓ | Trovagene INC | — | EXIT | Sold out |